(1,2,6,7-3H)Testosterone

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
(1,2,6,7-3H)Testosterone
Accession Number
DB14093
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
  • Testosterone, 1,2,6,7-H-3
Categories
Not Available
UNII
P57HP4MCQZ
CAS number
67308-98-9
Weight
Average: 296.463
Monoisotopic: 296.241827085
Chemical Formula
C19H28O2
InChI Key
MUMGGOZAMZWBJJ-JQSYSRDDSA-N
InChI
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1/i3T,4T,7T,9T/t3?,4?,7?,9?,14-,15-,16-,17-,18-,19-
IUPAC Name
(1S,3aS,3bR,9aR,9bS,11aS)-1-hydroxy-9a,11a-dimethyl(4,5,8,9-3H4)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
SMILES
[3H]C1C([3H])C2=CC(=O)C([3H])C([3H])[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
(R)-warfarinThe therapeutic efficacy of (R)-warfarin can be increased when used in combination with (1,2,6,7-3H)Testosterone.
(S)-WarfarinThe therapeutic efficacy of (S)-Warfarin can be increased when used in combination with (1,2,6,7-3H)Testosterone.
4-hydroxycoumarinThe therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with (1,2,6,7-3H)Testosterone.
AbciximabThe therapeutic efficacy of Abciximab can be increased when used in combination with (1,2,6,7-3H)Testosterone.
AcenocoumarolThe therapeutic efficacy of Acenocoumarol can be increased when used in combination with (1,2,6,7-3H)Testosterone.
Acetylsalicylic acidThe therapeutic efficacy of Acetylsalicylic acid can be increased when used in combination with (1,2,6,7-3H)Testosterone.
AlteplaseThe therapeutic efficacy of Alteplase can be increased when used in combination with (1,2,6,7-3H)Testosterone.
AmediplaseThe therapeutic efficacy of Amediplase can be increased when used in combination with (1,2,6,7-3H)Testosterone.
AnagrelideThe therapeutic efficacy of Anagrelide can be increased when used in combination with (1,2,6,7-3H)Testosterone.
AncrodThe therapeutic efficacy of Ancrod can be increased when used in combination with (1,2,6,7-3H)Testosterone.
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
35147838

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0333 mg/mLALOGPS
logP2.99ALOGPS
logP3.37ChemAxon
logS-3.9ALOGPS
pKa (Strongest Acidic)18.52ChemAxon
pKa (Strongest Basic)-0.88ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area37.3 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity84.43 m3·mol-1ChemAxon
Polarizability34.06 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on June 18, 2018 11:59 / Updated on November 02, 2018 07:50